Results 21 to 30 of about 134,564 (250)

Polymicrobial Endocarditis in Intravenous Heroin and Fentanyl Abuse [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2013
Infective endocarditis is a life threatening condition with a high mortality rate. Intravenous Drug Abusers (IVDA) are more likely to acquire endocarditis.
Raman Mehrzad   +2 more
doaj   +1 more source

Infective endocarditis is associated with worse outcomes in stroke: A Thailand National Database Study. [PDF]

open access: yes, 2020
BACKGROUND: There is lack of data on the association between infective endocarditis (IE) and outcomes of mortality and complications is stroke. We aimed to compare characteristics and outcomes of stroke patients with and without IE.
Mamas
core   +1 more source

Endocarditis With Complete Heart Block

open access: yesJournal of Investigative Medicine High Impact Case Reports, 2016
Gram-negative bacterial endocarditis causes 5% of all bacterial endocarditis. Among gram-negative bacteria, Klebsiella species are rare causes of native valve endocarditis.
Saad Ullah MD   +6 more
doaj   +1 more source

Quadravalvular Noninfectious Endocarditis

open access: yesJACC: Case Reports, 2019
Nonbacterial thrombotic endocarditis is characterized by sterile thrombi on cardiac valves. This report describes the case of nonbacterial endocarditis without pathologic findings of fibrin or platelet deposition. Quadrivalvular endocarditis was found to
Peter P. Vlismas, MD   +4 more
doaj   +1 more source

Clinical Features and Outcomes of Streptococcus anginosus Group Infective Endocarditis : A Multicenter Matched Cohort Study [PDF]

open access: yes, 2021
Although Streptococcus anginosus group (SAG) endocarditis is considered a severe disease associated with abscess formation and embolic events, there is limited evidence to support this assumption.
Miró, José M.   +42 more
core   +1 more source

KLF5 Downregulation Links Impaired BNIP3‐Mediated Mitophagy to Inflammatory Valve Remodeling in Calcific Aortic Valve Disease

open access: yesAdvanced Science, EarlyView.
In human CAVD, KLF5 is reduced in VIC‐rich regions and remodeling/stress‐associated VIC states. In VICs, KLF5 sustains BNIP3 promoter activity and BNIP3‐mediated mitophagy, thereby limiting cytosolic mtDNA accumulation. KLF5 loss weakens mitochondrial quality control and enhances mtDNA‐sensitive STING/NF‐κB/NLRP3 inflammatory signaling under osteogenic
Jin‐Hui Bian   +13 more
wiley   +1 more source

Optimizing treatment of proximal thoracic aortic graft infectionsCentral MessagePerspective

open access: yesJTCVS Open
Objectives: To describe treatment, assess outcomes, and identify risk factors for primary infection, reinfection, and death in patients with proximal thoracic aortic graft infection.
Matthew A. Thompson, MD   +10 more
doaj   +1 more source

138. Endocarditis, incidencia, microbiología y terapia, experiencia del centro del Corazón de berlín

open access: yesCirugía Cardiovascular, 2010
Exponer nuestra experiencia de más de 20 años en el tratamiento quirúrgico de las endocarditis de válvulas cardíacas, asi como la epidemiología y naturaleza microbiológica de las mismas.
T.E. Chávez, M. Musci, R. Hetzer
doaj   +1 more source

Infective Endocarditis as the Cause of Death: A Population based Study in Portugal, from 2002 to 2018

open access: yesActa Médica Portuguesa, 2021
Introduction: Infective endocarditis presents a high rate of morbidity and mortality. Population-based studies addressing mortality caused by infective endocarditis in Portugal are scarce.
Catarina de Sousa   +2 more
doaj   +1 more source

Hyperbranched poly‐L‐lysine surface‐engineered bioprosthetic heart valves with anti‐calcification, anti‐infection, and durability

open access: yesBMEMat, EarlyView.
The challenges of bioprosthetic heart valves (BHV) with respect to calcification, infection, and poor durability are tackled by surface engineering of hyperbranched poly‐L‐lysine (HBPL), providing a translational solution to improve long‐term valve performance.
Pai Peng   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy